These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 15086275)

  • 1. Treatment of anxiety and depression in transplant patients: pharmacokinetic considerations.
    Crone CC; Gabriel GM
    Clin Pharmacokinet; 2004; 43(6):361-94. PubMed ID: 15086275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalised anxiety disorder in elderly patients : epidemiology, diagnosis and treatment options.
    Flint AJ
    Drugs Aging; 2005; 22(2):101-14. PubMed ID: 15733018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological treatment of anxiety in the medically ill patient.
    Rubey RN; Lydiard RB
    Semin Clin Neuropsychiatry; 1999 Apr; 4(2):133-47. PubMed ID: 10378956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing depression in patients with advanced heart failure awaiting transplantation.
    Harris J; Heil JS
    Am J Health Syst Pharm; 2013 May; 70(10):867-73. PubMed ID: 23640347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citalopram and Cannabidiol: In Vitro and In Vivo Evidence of Pharmacokinetic Interactions Relevant to the Treatment of Anxiety Disorders in Young People.
    Anderson LL; Doohan PT; Oldfield L; Kevin RC; Arnold JC; Berger M; Amminger GP; McGregor IS
    J Clin Psychopharmacol; 2021 Sep-Oct 01; 41(5):525-533. PubMed ID: 34121064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of alternative antidepressant agent initiation among U. S. veterans diagnosed with depression.
    Kim HM; Zivin K; Ganoczy D; Pfeiffer P; Hoggatt K; McCarthy JF; Downing K; Valenstein M
    Pharmacoepidemiol Drug Saf; 2010 Oct; 19(10):1049-56. PubMed ID: 20629192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-line pharmacotherapy approaches for generalized anxiety disorder.
    Davidson JR
    J Clin Psychiatry; 2009; 70 Suppl 2():25-31. PubMed ID: 19371504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal management of anxiety in older patients.
    Weiss KJ
    Drugs Aging; 1996 Sep; 9(3):191-201. PubMed ID: 8877313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence of psychiatric disorders in French general practice using the patient health questionnaire: comparison with GP case-recognition and psychotropic medication prescription].
    Norton J; de Roquefeuil G; David M; Boulenger JP; Ritchie K; Mann A
    Encephale; 2009 Dec; 35(6):560-9. PubMed ID: 20004287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy of generalized anxiety disorder.
    Davidson JR
    J Clin Psychiatry; 2001; 62 Suppl 11():46-50; discussion 51-2. PubMed ID: 11414551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The acute treatment of anxiety and depression.
    Swinson RP
    Psychiatr J Univ Ott; 1989 Jun; 14(2):375-8; discussion 379-80. PubMed ID: 2569748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of psychotropic drugs to treat anxiety in the elderly.
    Gomez GE; Gomez EA
    J Psychosoc Nurs Ment Health Serv; 1994 Dec; 32(12):30-4. PubMed ID: 7714850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of pharmacogenetics in the treatment of depression and anxiety disorders.
    Schosser A; Kasper S
    Int Clin Psychopharmacol; 2009 Nov; 24(6):277-88. PubMed ID: 19738481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychopharmacologic treatment of anxiety in the medically ill elderly patient: special considerations.
    Stoudemire A; Moran MG
    J Clin Psychiatry; 1993 May; 54 Suppl():27-33; discussion 34-6. PubMed ID: 8099576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically relevant drug interactions in anxiety disorders.
    Muscatello MR; Spina E; Bandelow B; Baldwin DS
    Hum Psychopharmacol; 2012 May; 27(3):239-53. PubMed ID: 22311403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognizing the drug-resistant patient in anxiety and depression.
    Laage TA
    Med Clin North Am; 1988 Jul; 72(4):897-909. PubMed ID: 2897513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lu-AA21004, a multimodal serotonergic agent, for the potential treatment of depression and anxiety.
    Adell A
    IDrugs; 2010 Dec; 13(12):900-10. PubMed ID: 21154150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and psychopharmacology of anxiety in medical patients.
    Stoudemire A
    J Clin Psychiatry; 1996; 57 Suppl 7():64-72; 73-5. PubMed ID: 8690699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current treatment of depression and agitation in the elderly -- clinical use of trazodone].
    Osváth P
    Neuropsychopharmacol Hung; 2013 Sep; 15(3):147-55. PubMed ID: 24108179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to manage anxious patients who are depressed.
    Sussman N
    J Clin Psychiatry; 1993 May; 54 Suppl():8-16; discussion 17-20. PubMed ID: 8099581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.